Altamira Therapeutics Provides Business Update
28 mai 2024 10h31 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, May 28, 2024 (GLOBE NEWSWIRE) -- Achieved significant improvement in handling and transport stability of RNA nanoparticlesPursuing partnering opportunities with AM-125 legacy...
Evaxion Announces Business Update and First Quarter 2024 Financial Results
28 mai 2024 08h21 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, May 28, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology™...
BioRestorative Therapies Provides First Quarter 2024 Business Update
14 mai 2024 16h10 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
14 mai 2024 16h05 HE
|
SeaStar Medical Holding Corporation
DENVER, May 14, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary...
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
07 mai 2024 08h00 HE
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update Announced positive feedback from both FDA and EMA on the regulatory path for the Phase 3...
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
17 avr. 2024 16h00 HE
|
SeaStar Medical Holding Corporation
DENVER, April 17, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary...
DHT Holdings, Inc. Business Update
11 avr. 2024 16h15 HE
|
DHT Holdings, Inc.
HAMILTON, BERMUDA, April 11, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update: For the first quarter of 2024, the Company estimates time...
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
10 avr. 2024 08h00 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, April 10, 2024 (GLOBE NEWSWIRE) -- Management to host conference call today, April 10, at 8.30 a.m. EDTRNA delivery business progressing with new collaborations, potential new...
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
09 avr. 2024 01h00 HE
|
ONWARD Medical NV
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
04 avr. 2024 08h45 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...